CTSD and prostate cancer: The exosomal (CD9- CD81-SCARB2) (average enrichment 2.40) and lysosomal (CTSD- LAMP2- CTSZ- SPNS1- PSAP) (average enrichment 4.15) proteins were also enriched in exosomes from prostate cancer patients.